401 – 410 of 585
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
(
- Contribution to journal › Article
-
Mark
Health-related quality of life after chemotherapy cycle in breast cancer in Iran
(
- Contribution to journal › Article
-
Mark
Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study
(
- Contribution to journal › Article
-
Mark
PKA-induced phosphorylation of ER alpha at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
(
- Contribution to journal › Article
-
Mark
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
(
- Contribution to journal › Article
-
Mark
Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival
(
- Contribution to journal › Article
-
Mark
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome
(
- Contribution to journal › Article
-
Mark
Cyclin D1, Id1 and EMT in breast cancer
(
- Contribution to journal › Article
-
Mark
Genetic and Epigenetic Characterisation of Breast Tumours
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Value of post-operative reassessment of estrogen receptor alpha expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer
(
- Contribution to journal › Article